Next Generation Wound Care Products for the World
Who we are
LifeScience PLUS is a medical device company committed to developing and marketing innovative next-generation wound care technology. Through our line of BloodSTOP® wound care products, we have created a unique and revolutionary hemostatic matrix. BloodSTOP® is a plant-derived, hydrophilic material that, when properly applied, will actively aid blood coagulation and create a physical barrier and an environment for improved wound healing.
The BloodSTOP product family is at the forefront of a new generation of wound care products for medical and dental industries that are not only more practical to administer but also more effective and palliative for the patient.
LifeScience PLUS founding members recognized early on the need for wound care products that could address the disadvantages of traditional dressings and adhesive bandages. Convenient, cost-effective and proven for a range of applications, the Company’s flagship BloodSTOP and BloodSTOP iX products are FDA cleared for external usage. BloodSTOP is CE certified for external use, and BloodSTOP iX for external and internal use, in markets outside the U.S and Europe. LifeScience PLUS has identified and is actively exploring future indications for the medical professional marketplace based on clinical data and feedback from the medical community.
The Latest News
LSP supports US Armed Services Charity Run
LifeSciencePLUS PRESS RELEASE
July 18, 2014
LifeScience PLUS is honored to be the Run Finale Venue Sponsor for Always Brothers Foundation's 100 Miles Memorial Run on July 26th in Seattle. The 100 Mile Memorial Run will honor the fallen U.S. service men and women who lost their lives in service to their country during the Iraq and Afghanistan Wars. Money raised will be donated to the education funds of children of fallen Marines and Navy Corpsmen.
ALWAYS BROTHERS, a fraternal organization of service veterans, "represents those that have given the ultimate sacrifice to help support the families of those who are no longer with us."
LifeSciencePLUS PRESS RELEASE
December 5, 2013
LifeScience PLUS announced today that it has acquired exclusive patent rights to US and corresponding foreign patents covering water-soluble, oxidized - etherified regenerated cellulose materials. CEO and President of LifeScience PLUS, Vicky Feng, said today that while her company has for several years sold its Hemostatic BloodSTOP and BloodSTOP iX wound care products under license from the original owners of US Patent 7,262,181 which was granted in 2007, the company has been successful in negotiating an exclusive license with full rights to sub-license and otherwise enforce the patents worldwide. She further indicated that her company is considering the implementation of an industry-wide licensing program intended to insure that all covered products sold by the company's licensees are manufactured and marketed in accordance with the highest possible safety standards.
LifeSciencePLUS, Inc., is pleased to announce the recertification of its Class IIb CE Mark Certification for the BloodSTOP® line of topical hemostats. The recertification has been extended to include bleeding control for people on anti-coagulant medications.
UCSF preclinical study done in conjunction with University Hospital Pellegrin in France shows BloodSTOP iX® controls bleeding up to three times faster than Gelfoam or Surgicel.
Watch the news story which covered BloodSTOP products from ABC7 News, KGO-TV, San Francisco.
LifeScience PLUS, Inc., announces today that it has begun supplying its proprietary hemostat technology to the manufacturer of Curad wound care products for both a Curad brand and a Walgreens brand hemostat product.